Venture Capital

Atraverse Medical: $12.5 Million Raised To Develop Left-Heart Access Technology

By Amit Chowdhry ● May 28, 2024

San Diego-based medical device company Atraverse Medical announced the FDA clearance of its HOTWIRE radiofrequency (RF) guidewire, a novel device that enables zero exchange left-heart access while also acting as a rail for catheter-based therapy systems. The company also announced the oversubscription of its seed round at $12.5 million.

Truveris: Pharmacy Cost Containment Company Closes $15 Million

By Amit Chowdhry ● May 28, 2024

Truveris, a leader in pharmacy cost containment and program performance, announced it has raised $15 million in Series E investment led by two lead investors: Canaan Partners and New Leaf Venture Partners.

Capchase: SaaS-Based Revenue Acceleration Platform Secures €105 Million

By Amit Chowdhry ● May 28, 2024

Capchase, a revenue acceleration platform for Software-as-a-Service (SaaS) companies, announced it has secured a €105 million credit facility warehouse led by Deutsche Bank. This new funding contributes to the $1+ billion in combined debt and equity financing Capchase has received since its founding in 2020.

Rain AI: $8.1 Million Raised To Build Cost-Efficient Computing Hardware

By Amit Chowdhry ● May 28, 2024

Epic Venture Partners announced it has invested $8.1 million into Rain AI (a Sam Altman-backed startup). This was part of Rain AI's $25 million Series A extension round. Rain AI is an AI chip startup headed by CEO William Passo, with a goal of building cost- and energy-efficient AI hardware.

NuFund: An Interview With President Serhat Pala

By Amit Chowdhry ● May 27, 2024

NuFund Venture Group is a new wave of angel investors with a new fund model that invests in new technology leaders. Pulse 2.0 interviewed NuFund Venture Group President Serhat Pala to learn more about the firm.

Plume Network: Modular EVM Layer-2 Company Secures $10 Million

By Amit Chowdhry ● May 27, 2024

Plume, a modular EVM Layer-2 built to bring any real-world asset (RWA) on-chain, has raised $10 million in a seed funding round led by Haun Ventures with participation from Galaxy Ventures, Superscrypt, A Capital, SV Angel, Portal Ventures, Reciprocal Ventures, and others. And prominent angels include founders and executives of leading projects such as Anthony Ramirez of Wormhole Labs, Calvin Liu of Eigenlayer, Zon of Initia, Andrew Kang of Mechanism, Jeff Feng & Jayendra Jog of Sei Network, Adam Lawrence of rwa.xyz, Austin King & Tyler Tarsi of Omni, and more.

xAI Raises $6 Billion At $24 Billion Valuation

By Amit Chowdhry ● May 27, 2024

xAI, a company founded by Elon Musk that builds artificial intelligence to accelerate human scientific discovery, announced it has raised $6 billion at a valuation of $24 billion. The Series B funding included participation from Valor Equity Partners, Vy Capital, Andreessen Horowitz, Sequoia Capital, Fidelity Management & Research Company, Prince Alwaleed Bin Talal and, Kingdom Holding, and others.

Steno: $46 Million Raised And ‘Transcript Genius’ Launched

By Amit Chowdhry ● May 27, 2024

Steno, a tech-enabled provider of legal support and court reporting services, announced that it launched a first-of-its-kind generative AI tool for transcript analysis called Transcript Genius. This tool transforms how attorneys interact with transcripts. Along with the unveiling of Transcript Genius, Steno also announced the completion of $46 million in additional capital.

Brixton Biosciences: $33 Million Closed To Develop Novel Therapies For Chronic And Acute Pain

By Amit Chowdhry ● May 27, 2024

Brixton Biosciences, a spin-out from Massachusetts General Brigham and a clinical-stage life sciences company developing novel therapies for chronic and acute pain, announced that it closed a $33 million Series B funding round. Schooner Capital led the round, which also included SV Health Investors, Sparta Group, Excelestar Ventures, PV Capital Management, and Catalyst Health Ventures.

Ndustrial: AI-Based Energy Intensity Platform Company Raises $18.5 Million

By Amit Chowdhry ● May 27, 2024

Ndustrial, an AI-powered energy intensity platform for industry, today the initial closing of $18.5 million in a Series B funding round co-led by ABB and GS Energy, joining existing partners such as Clean Energy Ventures and ENGIE New Ventures.

Lumo: Connected Irrigation Company Secures $7 Million

By Amit Chowdhry ● May 27, 2024

Lumo, a connected irrigation company helping growers save time, money, and water with patented smart-valve technology, announced it has raised a $7 million funding round from Active Impact Investments and Fall Line Capital.

SmarterDx: AI-Based Hospital Revenue Integrity And Quality Company Raises $50 Million

By Amit Chowdhry ● May 27, 2024

SmarterDx, a leader in clinical AI for revenue integrity and care quality, announced it has secured $50 million in Series B funding led by Transformation Capital. This funding round also includes continued investments from Bessemer Venture Partners, Flare Capital Partners, and Floodgate Fund, bringing the total funding to date to $71 million. This investment will drive product innovation that will create additional value for health systems and support scale as the company expands.

OptMyCare: Healthcare And Risk Management Platform Raises $3 Million

By Amit Chowdhry ● May 27, 2024

OptMyCare, a clinically engineered AI platform in healthcare and risk management, announced that it raised $3 million in Series A financing from a group of investors led by LiveOak Ventures.

Sands Capital: $555 Million Life Sciences Pulse Fund III Closed

By Amit Chowdhry ● May 27, 2024

Sands Capital, an active and long-term investor in leading innovative businesses globally, announced the closing of its third life sciences fund, Sands Capital Life Sciences Pulse Fund III (Pulse III), at $555 million. Pulse III was met with high demand from existing and new limited partners. This closing increases total Pulse strategy capital commitments to $1.3 billion, including Sands Capital Life Sciences Pulse Fund (Pulse I) and Sands Capital Life Sciences Pulse Fund II (Pulse II).